DorsaVi Ltd (ASX: DVL) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Dorsavi Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $6.68 million
P/E Ratio N/A
Dividend Yield N/A
Shares Outstanding 351.43 million
Earnings per share -0.007
Dividend per share N/A
Year To Date Return -53.66%
Earnings Yield N/A
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

DorsaVi Ltd (ASX: DVL)
Latest News

DVL ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About DorsaVi Ltd

DorsaVi Ltd is engaged in a distribution of innovative motion analysis technologies. It makes wearable sensors, software, and sophisticated algorithms that measure movement and muscle activation at around 200 frames per second. The company's products include ViSafe (Workplace), ViMove (Clinic), ViPerform (Elite Sports), and others. The firm operates in two segments: Clinical; Workplace. Its geographical segments are Australia, Europe, and the United States.

DVL Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
07 Dec 2021 $0.02 $0.00 0.00% 683,547 $0.02 $0.02 $0.02
06 Dec 2021 $0.02 $0.00 0.00% 1,057,948 $0.02 $0.02 $0.02
03 Dec 2021 $0.02 $0.00 0.00% 538,967 $0.02 $0.02 $0.02
02 Dec 2021 $0.02 $0.00 0.00% 506,438 $0.02 $0.02 $0.02
01 Dec 2021 $0.02 $0.00 0.00% 18,624 $0.02 $0.02 $0.02
30 Nov 2021 $0.02 $0.00 0.00% 472,111 $0.02 $0.02 $0.02
26 Nov 2021 $0.02 $0.00 0.00% 143,286 $0.02 $0.02 $0.02
25 Nov 2021 $0.02 $0.00 0.00% 120,272 $0.02 $0.02 $0.02
24 Nov 2021 $0.02 $0.00 0.00% 255,258 $0.02 $0.02 $0.02
23 Nov 2021 $0.02 $0.00 0.00% 1,549,094 $0.02 $0.02 $0.02
19 Nov 2021 $0.02 $0.00 0.00% 802,148 $0.02 $0.02 $0.02
18 Nov 2021 $0.02 $0.00 0.00% 149,600 $0.02 $0.02 $0.02
17 Nov 2021 $0.02 $0.00 0.00% 206,750 $0.02 $0.02 $0.02
16 Nov 2021 $0.02 $0.00 0.00% 875,983 $0.02 $0.02 $0.02
15 Nov 2021 $0.02 $0.00 0.00% 64,834 $0.02 $0.02 $0.02
12 Nov 2021 $0.02 $0.00 0.00% 52,627 $0.02 $0.02 $0.02
11 Nov 2021 $0.02 $0.00 0.00% 311,377 $0.02 $0.02 $0.02
09 Nov 2021 $0.02 $0.00 0.00% 59,016 $0.02 $0.02 $0.02

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
07 Oct 2021 Michael Panaccio Issued 550 $11,000
Issue of options. Reported value seems typo, collected calc value.
07 Oct 2021 Caroline Elliott Issued 550 $11,000
Issue of options. Reported value seems typo, Collected as per calc.
07 Oct 2021 Gregory Tweedly Issued 750 $15,018
Issue of options.
07 Oct 2021 Ashraf Attia Issued 550 $11,000
Issue of options. Reported value seems typo, Collected as per calc.
08 Sep 2021 Andrew Ronchi Buy 205 $4,986
On-market trade.
05 Jul 2021 Caroline Elliott Issued 407 $11,000
Issue of options. Reported value seems typo, Collected as per calc.
05 Jul 2021 Gregory Tweedly Issued 556 $15,018
Issue of options.
05 Jul 2021 Michael Panaccio Issued 407 $11,000
Issue of options. Reported value seems typo, collected calc value.
05 Jul 2021 Ashraf Attia Issued 407 $11,000
Issue of options. Reported value seems typo, Collected as per calc.
08 Apr 2021 Caroline Elliott Issued 297 $11,000
Issue of options. Reported value seems typo,
Collected as per calc.
08 Apr 2021 Michael Panaccio Issued 297 $11,000
Issue of options. Reported value seems typo, collected calc value.
08 Apr 2021 Ashraf Attia Issued 297 $11,000
Issue of options. Reported value seems typo, Collected as per calc.
08 Apr 2021 Gregory Tweedly Issued 405 $15,018
Issue of options.
08 Jan 2021 Gregory Tweedly Issued 366 $15,018
Issue of options.
08 Jan 2021 Ashraf Attia Issued 268 $11,000
Issue of options. Reported value seems typo, collected calc value.
08 Jan 2021 Michael Panaccio Issued 268 $11,000
Issue of options. Reported value seems typo, collected calc value.
08 Jan 2021 Caroline Elliott Issued 268 $10,731
Issue of options.
23 Dec 2020 Andrew Ronchi Issued 2 $75,804
Issue of securities.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Michael Panaccio Non-Executive Director May 2008
Mr Panaccio is one of the founding directors of Starfish Ventures Pty Ltd. He was formerly an Investment Manager with JAFCO Investment (Asia Pacific). Prior to joining JAFCO, Michael was Head of the Department of Molecular Biology at the Victorian Institute of Animal Sciences. Michael has previously been a director of technology businesses in Australia and the US including ImpediMed Ltd, SIRTeX Medical Ltd, Protagonist Therapeutic Inc and Energy Response Pty Ltd. He is Member of Risk Committee.
Ms Caroline Ann Elliott Non-Executive Director Nov 2017
Ms Elliott is currently a Director of the National Film and Sound Archive of Australia, St John's Ambulance Australia (Vic) and Wiltrust Nominees Pty Ltd. She has previously held non-executive director roles at Cell Therapies Pty Ltd, Peter MacCallum Cancer Centre and the Public Transport Ombudsman Limited. She is currently the Chief Executive Officer at apparel business, The Propel Group Pty Ltd, and was previously the CFO and Company Secretary at Optal Ltd. She is Chair of Risk Committee.
Dr Andrew James Ronchi Chief Executive OfficerExecutive Director Feb 2008
Dr Ronchi was a practising physiotherapist both at an AFL club and in private practice. He has also been founding partner in two physiotherapy centres, the largest of these employing 28 staff (including 13 physiotherapists).
Mr Ashraf Attia Non-Executive Director Jul 2008
Mr Attia has had senior management experience in multinational operations for over 30 years within the medical devices, biotechnology and diagnostics industries. He is currently Chief Executive Officer of Bionic Vision Technologies. Prior to Bionic Vision, Ash held the position of Vice President of Asia Pacific, Middle East and Israel at TransMedics Inc. He has held several senior executive roles with global medical devices organizations and has experience in the areas of commercialization, business development, clinical, regulatory, R&D, strategic marketing, sales and distribution management. He is Member of Risk Committee.
Mr Brendan Case Company Secretary Oct 2013
-
Damian Connellan Chief Financial Officer
-
Joanna Goldin Clinical Manager
-
Brendan Case Company Secretary
-
Matthew May General Manager
-
Yasmine Pateras Workplace Manager
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Starfish Technology Fund II LP 60,597,345 17.27%
Starfish Technology Fund II Nominees A Pty Ltd 18,464,557 5.26%
Starfish Technology Fund II Nominees B Pty Ltd 18,464,557 5.26%
Pusen Medical Technology Australia Pty Ltd 13,500,000 3.85%
Ms Chunyan Niu 11,542,752 3.29%
Mr Bilalahmad 8,000,000 2.28%
Ar Bsm Pty Ltd <Ar Bsm A/C> 7,021,814 2.00%
Mr Salvatore Di Vincenzo 5,844,201 1.67%
Andrew Ronchi 5,675,171 1.62%
Bannaby Investments Pty Limited <Bannaby Super Fund A/C> 4,428,497 1.26%
449 Investments Pty Ltd <The A&R Hynes Family S/F A/C> 3,762,500 1.07%
Tanarny Super Fund Pty Ltd <Tanarny Super Fund A/C> 3,703,704 1.06%
Mr Bilal Ahmad 3,367,233 0.96%
Shadebridge Pty Ltd <The O Connor Family A/C> 3,268,563 0.93%
Ms Gabrielle Banay 3,233,482 0.92%
Drnewnham Super Pty Ltd <DRN Superannuation Fund A/C> 3,231,516 0.92%
Valence Holdings Pty Ltd The PW & CM Stinton <Superannuation Fund A/C> 3,000,000 0.85%
J P Morgan Nominees Australia Pty Limited 2,913,893 0.83%
Mr Stuart Andrew Lewin 2,829,000 0.81%
Buttonwood Nominees Pty Ltd 2,631,000 0.75%

Profile

since

Note